I did a little digging on Hygea and found 2 other nasdaq listed companies that had there contracts canceled by Hygea over the last few years. So it would seem Hygea is not a great customer to deal with.
I would expect the ASX is asking for an update on all MOUs as per the last query. I also think they will be asking when the company knew of all the major events listed in the July 30 company update and why they were not announced at that time. Maybe also some things that were in the Nasdaq prospects that haven been announced to the ASX. Probably a few other things too. time will tell.
At the end of the day, all this bad news is already in the price.
We could see this VS extended until there is something positive to announce like regulatory approvals or UK contract. Better to be suspended than drift lower on no news.
The only think I keep coming back too is how much money yacov keeps putting and Brendan's large options purchase. They must be confident things will turn around...
Also, we are almost at the end of another quarter. The first 6mth the company did c$3m. what if they do $2m for the sept quarter? That's $8m a year and moving in the right direction to meet Brendan's statement of being cash flow neutral by years end. That's definitely not doom and gloom.
- Forums
- ASX - By Stock
- GMV
- Ann: Trading Halt
Ann: Trading Halt, page-111
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online